Viewray Inc (VRAY) to Post FY2017 Earnings of ($1.08) Per Share, B. Riley Forecasts

Viewray Inc (NASDAQ:VRAY) – Stock analysts at B. Riley issued their FY2017 earnings per share estimates for Viewray in a report released on Thursday. B. Riley analyst A. D’silva forecasts that the company will post earnings per share of ($1.08) for the year. B. Riley has a “Buy” rating and a $13.50 price target on the stock. B. Riley also issued estimates for Viewray’s Q4 2017 earnings at ($0.23) EPS, Q1 2018 earnings at ($0.22) EPS, Q2 2018 earnings at ($0.21) EPS, Q3 2018 earnings at ($0.19) EPS, Q4 2018 earnings at ($0.19) EPS, FY2018 earnings at ($0.81) EPS, FY2019 earnings at ($0.51) EPS, FY2020 earnings at ($0.11) EPS and FY2021 earnings at $0.21 EPS.

A number of other equities analysts have also weighed in on VRAY. Mizuho restated a “buy” rating and issued a $12.00 target price on shares of Viewray in a research note on Wednesday, October 25th. Northland Securities restated a “buy” rating and issued a $10.00 target price on shares of Viewray in a research note on Friday, November 17th. ValuEngine lowered Viewray from a “hold” rating to a “sell” rating in a research note on Friday, December 1st. BidaskClub lowered Viewray from a “buy” rating to a “hold” rating in a research note on Saturday, December 9th. Finally, Cantor Fitzgerald restated an “overweight” rating on shares of Viewray in a research note on Friday, January 5th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and six have given a buy rating to the company. Viewray has an average rating of “Buy” and an average target price of $11.58.

Viewray (NASDAQ VRAY) opened at $7.88 on Monday. The firm has a market capitalization of $532.24, a PE ratio of -7.23 and a beta of 14.36. The company has a quick ratio of 1.20, a current ratio of 1.59 and a debt-to-equity ratio of -1.67. Viewray has a one year low of $4.40 and a one year high of $10.64.

Viewray (NASDAQ:VRAY) last announced its earnings results on Monday, November 13th. The company reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.12) by ($0.07). The business had revenue of $12.20 million during the quarter, compared to analyst estimates of $18.63 million. The business’s revenue for the quarter was up 2950.0% compared to the same quarter last year.

Several institutional investors have recently made changes to their positions in the company. Citadel Advisors LLC increased its position in shares of Viewray by 2,115.4% during the 4th quarter. Citadel Advisors LLC now owns 669,054 shares of the company’s stock valued at $6,195,000 after purchasing an additional 638,854 shares during the last quarter. BlackRock Inc. increased its position in shares of Viewray by 19.8% during the 4th quarter. BlackRock Inc. now owns 1,853,268 shares of the company’s stock valued at $17,160,000 after purchasing an additional 306,395 shares during the last quarter. Bank of New York Mellon Corp increased its position in shares of Viewray by 88.5% during the 4th quarter. Bank of New York Mellon Corp now owns 205,129 shares of the company’s stock valued at $1,901,000 after purchasing an additional 96,302 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of Viewray by 52.3% during the 4th quarter. Wells Fargo & Company MN now owns 57,571 shares of the company’s stock valued at $533,000 after purchasing an additional 19,769 shares during the last quarter. Finally, California Public Employees Retirement System bought a new position in shares of Viewray during the 4th quarter valued at about $317,000. Hedge funds and other institutional investors own 50.52% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Viewray Inc (VRAY) to Post FY2017 Earnings of ($1.08) Per Share, B. Riley Forecasts” was originally posted by American Banking News and is the property of of American Banking News. If you are reading this report on another website, it was copied illegally and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this report can be read at https://www.americanbankingnews.com/2018/02/12/viewray-inc-vray-to-post-fy2017-earnings-of-1-08-per-share-b-riley-forecasts.html.

About Viewray

ViewRay, Inc designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company’s software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered.

Earnings History and Estimates for Viewray (NASDAQ:VRAY)

Receive News & Ratings for Viewray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Viewray and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply